Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript
Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.61, expectations were $-0.85.
March 22nd, 2024 - News Transcripts
November 12th, 2023 - News Transcripts
August 15th, 2023 - News Transcripts
June 9th, 2023 - Hedge Funds IPOs News
February 20th, 2023 - Hedge Funds Insider Trading
Returns since its inception in May 2014 (through Feb 16th, 2024)